Jim Simons Profound Medical Corp. Transaction History

Renaissance Technologies LLC

$63.4 Billion
Q4 2024

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Profound Medical Corp. stock. As of the latest transaction made, Renaissance Technologies LLC holds 58,200 shares of PROF stock, worth $365,496. This represents 0.0% of its overall portfolio holdings.

Number of Shares

58,200

Previous 58,900 1.19%

Holding current value

$365,496

Previous $468,000 6.62%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	SELL	$6.98 - $8.96 $4,886 - $6,272	-700 Reduced 1.19%	58,200 $437,000
Q3 2024 Nov 13, 2024	BUY	$7.47 - $11.18 $439,983 - $658,502	58,900 New	58,900 $468,000
Q1 2024 May 13, 2024	SELL	$7.3 - $9.46 $23,360 - $30,272	-3,200 Reduced 14.61%	18,700 $160,000
Q4 2023 Feb 13, 2024	BUY	$7.85 - $11.18 $171,915 - $244,842	21,900 New	21,900 $186,000
Q3 2021 Nov 12, 2021	SELL	$13.6 - $17.88 $216,240 - $284,292	-15,900 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$16.0 - $20.59 $940,480 - $1.21 Million	-58,780 Reduced 78.71%	15,900 $260,000
Q1 2021 May 13, 2021	SELL	$19.16 - $28.09 $68,976 - $101,124	-3,600 Reduced 4.6%	74,680 $1.5 Million
Q4 2020 Feb 10, 2021	SELL	$16.4 - $22.9 $949,559 - $1.33 Million	-57,900 Reduced 42.52%	78,280 $1.61 Million
Q3 2020 Nov 13, 2020	BUY	$14.05 - $18.13 $327,365 - $422,429	23,300 Added 20.64%	136,180 $2.4 Million
Q2 2020 Aug 13, 2020	SELL	$9.41 - $16.94 $68,693 - $123,662	-7,300 Reduced 6.07%	112,880 $1.91 Million
Q1 2020 May 14, 2020	BUY	$6.88 - $19.7 $738,086 - $2.11 Million	107,280 Added 831.63%	120,180 $1.16 Million
Q4 2019 Feb 13, 2020	BUY	$6.4 - $11.95 $82,560 - $154,155	12,900 New	12,900 $147,000

Others Institutions Holding PROF

# of Institutions

Shares Held

13.6M

Call Options Held

3.9K

Put Options Held

1.4K

View Full List

About Profound Medical Corp.

Ticker PROF
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 20,851,300
Market Cap $131M
Description
Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system used for...

More about PROF

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account